|
Investors and shareholders review analyst reporting as one major source of verification that emerging healthcare companies are meeting milestones and reaching established goals. When you think of a person whose opinion counts most for a company, the CEO, Chairman or CFO probably come to mind. Unfortunately, most sophisticated investors will not take management's word for a company's prospects. The analyst who covers the stock, however, ranks right up there.
Investors and shareholders need independent verification that emerging healthcare companies are meeting milestones and reaching established goals. We provide value-added intelligence and insightful investment conclusions on those companies demonstrating real progress toward their vision while meeting quarterly expectation. Currently, half of all public companies have two or fewer analysts while 40-45% have no analyst coverage. It has also been stated that companies without analyst coverage tend to be traded at a discount of 20% to 30%.
Writing equity research is a very consuming job and our intensity to "get it right" reflects our personal commitment, ethics as well as our SEC certification. Our research is read and questioned by investors from the retail and institutional side to which we always take time to respond. It is about timely, credible, and insightful analysis; not a regurgitation of public information. If there is to be an investment decision; then depend on our thoroughness and quality of analysis finalized by a share purchase and valuation enhancement. Scimitar's comprehensive equity research is based on multiple approaches: detailed diligence, skepticism, translating expectation versus anticipation, evaluation and objectivity. We also remain open minded to contrary information as we initiate a thorough examination of the collected "intelligence" to develop an investment thesis. We strive for accuracy and completeness and restrict any influence or pressure for our investment thesis and valuation models.
We provide a number of services, including: Any time access - speak to "ME" about insights and diligence ranging from comparable sector trends to company trends; Written reports: company, industry, mid-quarter reports, daily insights and weekly updates, earnings reviews as well as thematic reports. We host investor meetings and non-deal road shows - providing access for senior and executive management. We also create custom metrics - possessing access to quantitative databases of financial and operating data including: historical and forecasted financial, operating and valuation data, stock price performance, and historical economic data. Our core competency extends our customized research products - including qualitative and quantitative analysis on current and historical metrics, sectors and competitors, merger and science specific research.
|
